601818:SSEChina Everbright Bank Co., Ltd. Class A Analysis
Data as of 2026-06-03 - not real-time
CN¥3.12
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
China Everbright Bank trades at a price multiple that is markedly below its industry peers, offering a compelling margin of safety for value‑oriented investors. The bank’s price‑to‑book ratio sits at a deep discount, and its dividend yield is among the highest in the sector, supported by a modest payout ratio that suggests sustainability. Technical indicators present a mixed picture: the 20‑day moving average sits below the 50‑day average, signaling a short‑term bearish bias, yet the MACD has turned bullish and the price is hovering just above a key support level, limiting downside risk.
With a very low beta, the stock shows limited sensitivity to broader market swings, while volatility remains moderate. The balance sheet is bolstered by ample cash relative to debt, and the bank continues to generate solid operating cash flow. These fundamentals, combined with an attractive dividend and a valuation that appears significantly undervalued, make the stock a candidate for accumulation, particularly for investors with a longer horizon.
With a very low beta, the stock shows limited sensitivity to broader market swings, while volatility remains moderate. The balance sheet is bolstered by ample cash relative to debt, and the bank continues to generate solid operating cash flow. These fundamentals, combined with an attractive dividend and a valuation that appears significantly undervalued, make the stock a candidate for accumulation, particularly for investors with a longer horizon.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near technical support
- Bullish MACD crossover
- High dividend yield offering immediate income
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Valuation gap relative to peers
- Sustained cash generation
- Stable dividend policy
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Deep undervaluation on price multiples
- Strong balance sheet with ample liquidity
- Low beta and defensive sector profile
Key Metrics & Analysis
Financial Health
Revenue Growth-7.10%
Profit Margin42.93%
P/E Ratio5.6
ROE6.54%
ROA0.53%
P/B Ratio0.4
Op. Cash FlowCN¥69.8B
Industry P/E16.3
Technical Analysis
TrendBearish
RSI47.3
SupportCN¥3.06
ResistanceCN¥3.16
MA 20CN¥3.12
MA 50CN¥3.17
MA 200CN¥3.44
MACDBullish
VolumeStable
Fear & Greed Index92.64
Valuation
GradeUndervalued
TypeValue
Dividend Yield6.03%
Risk Assessment
Beta0.16
Volatility9.67%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.